SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Godavari Drugs - Quaterly Results

28 May 2026 Evaluate
The sales moved up 30.04% to Rs. 331.63 millions for the March 2026 quarter as compared to Rs. 255.03 millions during the year-ago period.A comparatively good net profit growth of 44.34% to Rs. 12.89 millions was reported for the quarter ended March 2026 compared to Rs. 8.93 millions of previous same quarter.The company reported a degrowth in operating Profit to 30.80 millions from 32.19 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 331.63 255.03 30.04 1058.08 1133.50 -6.65 1058.08 1133.50 -6.65
Other Income 1.41 1.05 34.29 8.05 9.77 -17.60 8.05 9.77 -17.60
PBIDT 30.80 32.19 -4.32 111.19 128.04 -13.16 111.19 128.04 -13.16
Interest 9.56 11.07 -13.64 39.80 47.32 -15.89 39.80 47.32 -15.89
PBDT 22.28 21.12 5.49 74.94 80.72 -7.16 74.94 80.72 -7.16
Depreciation 6.12 6.72 -8.93 24.32 24.48 -0.65 24.32 24.48 -0.65
PBT 16.16 14.40 12.22 50.62 56.24 -9.99 50.62 56.24 -9.99
TAX 3.27 5.47 -40.22 9.74 12.45 -21.77 9.74 12.45 -21.77
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 12.89 8.93 44.34 40.88 43.79 -6.65 40.88 43.79 -6.65
Equity 101.27 75.30 34.49 101.27 75.30 34.49 101.27 75.30 34.49
PBIDTM(%) 9.29 12.62 -26.42 10.51 11.30 -6.97 10.51 11.30 -6.97

Godavari Drugs Share Price

122.50 -0.25 (-0.20%)
04-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.35
Dr. Reddys Lab 1267.05
Cipla 1397.75
Zydus Lifesciences 1085.45
Lupin 2248.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×